Capricor Therapeutics Insider Trades

CAPR

Track insider trading activity from Capricor Therapeutics executives and directors. See which insiders are buying and selling CAPR stock.

Trades Last 12 Months

CAPR Price

All Insider Trades for Capricor Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bergmann Anthony CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
May 18, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$84k 3,000 shares
$28.02
$27.64
Litvack Frank Director
Holding Value $0 0 shares
Last Trade
May 13, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$119k 3,937 shares
$30.33
$27.64
Krasney Karen Evp, GENERAL COUNSEL
Holding Value $1.54M 55,547 shares
Last Trade
May 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$773k 25,000 shares
$30.91
$27.64
Sabar Karimah Es Director
Holding Value $4.45k 161 shares
Last Trade
Apr 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$242k 7,529 shares
$32.11
$27.64
Kelliher Mike Director
Holding Value $428k 15,500 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$385k 15,500 shares
$24.81
$27.64
Holding Value $428k 15,500 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$553k 22,280 shares
$24.81
$27.64
Musket David B Director
Holding Value $428k 15,500 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$385k 15,500 shares
$24.81
$27.64
Marban Linda CHIEF EXECUTIVE OFFICER
Holding Value $2.76M 100,000 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.72M 157,500 shares
$23.63
$27.64
Gotwals Philip J Director
Holding Value $428k 15,500 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$385k 15,500 shares
$24.81
$27.64
Holding Value $428k 15,500 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$385k 15,500 shares
$24.81
$27.64
Holding Value $1.59M 57,606 shares
Last Trade
Feb 27, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.8k 750 shares
$14.38
$27.64
Holding Value $196M 7,090,351 shares
Last Trade
Sep 20, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$15M 2,798,507 shares
$5.36
$27.64
Holding Value $0 0 shares
Last Trade
Apr 17, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$63.4k 14,772 shares
$4.29
$27.64
Manzo Louis Director
Holding Value $1.72M 62,147 shares
Last Trade
Feb 21, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.95k 452 shares
$4.31
$27.64
Ascheim Deborah Chief Medical Officer
Holding Value $1.38M 50,000 shares
Last Trade
Jul 24, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$620k 50,000 shares
$12.40
$27.64
Smith Rachel Vice President Of R&d
Holding Value $1.38M 50,000 shares
Last Trade
Jan 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$785k 50,000 shares
$15.70
$27.64
Kazam Joshua A Director
Holding Value $498k 18,000 shares
Last Trade
Jan 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$283k 18,000 shares
$15.70
$27.64
Holding Value $112M 4,049,959 shares
Last Trade
May 09, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$33.2M 1,145,161 shares
$29.00
$27.64
Gershell Leland CHIEF FINANCIAL OFFICER
Holding Value $29k 1,050 shares
Last Trade
Mar 16, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$26.3k 1,050 shares
$25.00
$27.64
Grasmick Louis J Director
Holding Value $2.13M 77,015 shares
Last Trade
Mar 16, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.78M 71,065 shares
$25.00
$27.64

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up